SMT201600372B - Compresse di ulipristal acetato - Google Patents

Compresse di ulipristal acetato

Info

Publication number
SMT201600372B
SMT201600372B SM201600372T SM201600372T SMT201600372B SM T201600372 B SMT201600372 B SM T201600372B SM 201600372 T SM201600372 T SM 201600372T SM 201600372 T SM201600372 T SM 201600372T SM T201600372 B SMT201600372 B SM T201600372B
Authority
SM
San Marino
Prior art keywords
ulipristal acetate
acetate tablets
tablets
ulipristal
acetate
Prior art date
Application number
SM201600372T
Other languages
English (en)
Inventor
Erin Gainer
Helene Guillard
Denis Gicquel
Marianne Henrion
Celine Gnakamene
Original Assignee
Hra Pharma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41621124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600372(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hra Pharma Lab filed Critical Hra Pharma Lab
Publication of SMT201600372B publication Critical patent/SMT201600372B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SM201600372T 2008-12-08 2016-10-13 Compresse di ulipristal acetato SMT201600372B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/329,865 US8512745B2 (en) 2008-12-08 2008-12-08 Ulipristal acetate tablets

Publications (1)

Publication Number Publication Date
SMT201600372B true SMT201600372B (it) 2017-01-10

Family

ID=41621124

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600372T SMT201600372B (it) 2008-12-08 2016-10-13 Compresse di ulipristal acetato

Country Status (28)

Country Link
US (5) US8512745B2 (it)
EP (2) EP3103445A1 (it)
JP (2) JP5784502B2 (it)
KR (1) KR101733533B1 (it)
CN (2) CN105267168A (it)
AU (1) AU2009326084B2 (it)
BR (1) BRPI0922796A2 (it)
CA (1) CA2745084C (it)
CO (1) CO6400186A2 (it)
CY (1) CY1118099T1 (it)
DK (1) DK2365800T3 (it)
ES (1) ES2596554T3 (it)
HK (1) HK1232134A1 (it)
HR (1) HRP20161262T1 (it)
HU (1) HUE030762T2 (it)
IL (1) IL213247A (it)
LT (1) LT2365800T (it)
MX (1) MX343358B (it)
NZ (1) NZ593498A (it)
PL (1) PL2365800T3 (it)
PT (1) PT2365800T (it)
RS (1) RS55209B1 (it)
RU (1) RU2492853C2 (it)
SI (1) SI2365800T1 (it)
SM (1) SMT201600372B (it)
UA (1) UA101863C2 (it)
WO (1) WO2010066749A2 (it)
ZA (1) ZA201104137B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615475C3 (de) * 1976-04-09 1984-05-03 Philips Patentverwaltung Gmbh, 2000 Hamburg Sonnenkollektor mit einer Abdeckung aus evakuierten Rohren
US8512745B2 (en) * 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
LT2419108T (lt) 2009-04-14 2016-12-27 Laboratoire Hra Pharma Kontracepcijos pagal poreikį būdas
EP2471537A1 (en) * 2010-12-30 2012-07-04 PregLem S.A. Treatment of pain associated with dislocation of basal endometrium
CN102727457B (zh) * 2011-04-08 2014-05-28 华润紫竹药业有限公司 稳定的醋酸优力司特制剂
FR2987271B1 (fr) 2012-02-28 2017-08-18 Hra Pharma Lab Combinaison de modulateurs selectifs du recepteur a la progesterone et d'anti-inflammatoires non steroidiens
WO2013175009A1 (en) 2012-05-25 2013-11-28 Laboratoire Hra-Pharma Ulipristal acetate for prevention and treatment of breast tumors
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
FR2997628B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
FR2999081B1 (fr) * 2012-12-06 2015-02-27 Hra Pharma Lab Dispersion solide d'un modulateur selectif du recepteur a la progesterone
CN103006595B (zh) * 2012-12-25 2018-04-06 江苏亚邦爱普森药业有限公司 制备醋酸优力司特片的方法
CN103006603B (zh) * 2013-01-11 2015-04-15 山东创新药物研发有限公司 醋酸乌利司他的固体分散体及固体制剂
CN103083326A (zh) * 2013-02-04 2013-05-08 四川尚锐生物医药有限公司 一种醋酸优力司特药物组合物
MX2015014199A (es) * 2013-04-10 2016-06-21 Preglem Sa Moduladores del receptor de progesterona para usarse en la terapia de fibromas uterinos.
CN104865215A (zh) * 2015-05-16 2015-08-26 南京海纳医药科技有限公司 一种醋酸乌利司他片剂及其溶出度测定方法
FR3060389B1 (fr) 2016-12-20 2019-05-31 Laboratoire Hra-Pharma Comprime enrobe comprenant de l'ulipristal acetate ou un de ses metabolites
WO2017216637A2 (en) 2017-08-04 2017-12-21 Alvogen Malta Operations (Row) Ltd Tablet form including ulipristal acetate and the methods for its preparation
CN107982230A (zh) * 2017-12-25 2018-05-04 郑州泰丰制药有限公司 一种醋酸乌利司他分散片及其制备方法
CN114137115B (zh) * 2021-11-26 2023-08-04 四川尚锐分析检测有限公司 一种采用lc-ms法检测血浆中醋酸优力司特及其代谢物的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
ZA939565B (en) 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
HU227198B1 (en) 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
ES2212912B1 (es) 2003-01-22 2005-10-01 Crystal Pharma, S.A. Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona.
JP2006519255A (ja) 2003-02-28 2006-08-24 アメリカ合衆国 １７α−アセトキシ−１１β−（４−Ｎ，Ｎ−ジメチルアミノフェニル）−１９−ノルプレグナ−４，９−ジエン−３，２０−ジオンの製造方法、その中間体及びそのような中間体の製造方法
DE602005014227D1 (de) 2004-03-10 2009-06-10 Bayer Schering Pharma Ag Zusammensetzungen aus drospirenon in molekularer dispersion
CN101166533A (zh) 2005-04-28 2008-04-23 惠氏公司 微粉化的tanaproget和含有它的组合物
DE602006007453D1 (de) * 2005-04-28 2009-08-06 Wyeth Corp Zusammensetzungen mit mikronisiertem tanaproget
US8475838B2 (en) 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
US8173626B2 (en) * 2006-03-08 2012-05-08 Danco Laboratories Llc Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
SI3263112T1 (sl) 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
CA2674776A1 (en) 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EA200970646A1 (ru) 2006-12-28 2009-12-30 Репрос Терапьютикс Инк. Способы и составы для улучшения биодоступности антипрогестинов
WO2008088935A2 (en) 2007-01-17 2008-07-24 Repros Therapeutics Inc. Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives
DK2148681T3 (en) 2007-04-20 2016-07-04 Preglem Sa Selective progesteronmodulatorer in the treatment of uterine bleeding
US20090117184A1 (en) 2007-11-05 2009-05-07 Sabine Fricke Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception
US8512745B2 (en) * 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets

Also Published As

Publication number Publication date
HUE030762T2 (en) 2017-05-29
JP6151727B2 (ja) 2017-06-21
CA2745084C (en) 2014-11-18
WO2010066749A2 (en) 2010-06-17
RS55209B1 (sr) 2017-01-31
HK1232134A1 (zh) 2018-01-05
WO2010066749A3 (en) 2010-08-05
AU2009326084A1 (en) 2011-07-07
CN105267168A (zh) 2016-01-27
US20120077790A1 (en) 2012-03-29
ZA201104137B (en) 2012-02-29
CA2745084A1 (en) 2010-06-17
CY1118099T1 (el) 2017-06-28
US20100144692A1 (en) 2010-06-10
HRP20161262T1 (hr) 2016-12-16
NZ593498A (en) 2012-07-27
CO6400186A2 (es) 2012-03-15
DK2365800T3 (en) 2016-10-24
MX343358B (es) 2016-11-03
US9844510B2 (en) 2017-12-19
EP2365800B1 (en) 2016-07-20
KR20110097936A (ko) 2011-08-31
KR101733533B1 (ko) 2017-05-10
JP5784502B2 (ja) 2015-09-24
AU2009326084B2 (en) 2014-06-05
JP2012511041A (ja) 2012-05-17
US20160287518A1 (en) 2016-10-06
PL2365800T3 (pl) 2017-03-31
IL213247A0 (en) 2011-07-31
RU2011127989A (ru) 2013-01-20
EP3103445A1 (en) 2016-12-14
MX2011006106A (es) 2011-06-24
US8512745B2 (en) 2013-08-20
LT2365800T (lt) 2016-11-10
ES2596554T3 (es) 2017-01-10
US20140228335A1 (en) 2014-08-14
UA101863C2 (uk) 2013-05-13
IL213247A (en) 2015-07-30
SI2365800T1 (sl) 2017-01-31
CN102245173A (zh) 2011-11-16
PT2365800T (pt) 2016-10-25
US20180064651A1 (en) 2018-03-08
US8735380B2 (en) 2014-05-27
EP2365800A2 (en) 2011-09-21
RU2492853C2 (ru) 2013-09-20
JP2015107994A (ja) 2015-06-11
BRPI0922796A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
SMT201600372B (it) Compresse di ulipristal acetato
DK2285411T3 (da) Nikotintabletsammensætninger
DK3090730T3 (da) Tabletter omfattende eltrombopag-olamin
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI0920521A2 (pt) combinação farmacêutica
BRPI1004940A2 (pt) composição farmacêutica
BRPI1015939A2 (pt) composição farmacêutica
ITVR20080024A1 (it) Struttura di tramoggia
DK2285413T3 (da) Farmaceutisk sammensætning
FR2935592B1 (fr) Poudrier
BRPI0921313A2 (pt) composição farmaucêutica
DE112008003753B8 (de) Reißverschluss
DK2271618T3 (da) Farmaceutiske forbindelser
DK2272763T3 (da) Blisterpakning-dispensermaskine
BR112012003149A2 (pt) composição farmacêutica
BRPI0912171A2 (pt) composição farmacêutica
BRPI0921301A2 (pt) composição farmacêutica
BRPI0909152A2 (pt) tabletes comprimidos
UA17978S (uk) Тумба декоративна
ES1071922Y (es) Adorno multiusos
DOP2009000016A (es) Composicion farmaceutica
ITUD20080017A1 (it) Filtro reversibile
TH105417B (th) ยาเม็ด
UA17225S (uk) Диван-ліжко
UA20335S (uk) Пігулка